Weight loss in HIV-infected patients.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  New England Journal of Medicine

• Publication date

  2002-10-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM200210173471623PMID 12393835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.

  2001cited by this paper
• Mitochondrial toxic effects and ribavirin.

  2001cited by this paper

• Chapter 162 – Cryptosporidium parvum (Cryptosporidiosis) Attack

  2016cites this paper
• COMBINED EFFECTS OF RIBAVIRIN AND DIAZINON ON HEPATIC , PANCREATIC AND KIDNEY BIOMARKERS IN FEMALE ALBINO RATS

  2016cites this paper
• Efecto del tratamiento antirretroviral en la respuesta virológica a interferón pegilado y ribavirina en pacientes coinfectados por el virus de la inmunodeficiencia humana y el virus de la hepatitis C

  2015cites this paper
• The effects and underlying mechanism of interferon therapy on body weight and body composition.

  2013cites this paper
• What the infectious disease physician needs to know about pegylated interferon and ribavirin.

  2013cites this paper
• Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.

  2012cites this paper
• Management and Treatment of Chronic Hepatitis C in HIV Patients

  2012cites this paper
• Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients.

  2011cites this paper
• Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.

  2011cites this paper
• A Brief Review on Immune Mediated Diseases

  2011cites this paper
• Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C Coinfection in a Patient with Human Immunodeficiency Virus Infection

  2011cites this paper
• HCV and HIV Coinfection

  2011cites this paper
• Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients.

  2010influential citation
• Viral hepatitis and HIV co-infection.

  2010cites this paper
• Efficacy and safety of pegylated interferon alpha‐2a therapy for chronic hepatitis C in HIV‐infected patients with haemophilia

  2009cites this paper
• Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B

  2009cites this paper
• Papel de tenofovir en la coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C

  2008cites this paper
• The impact of combination therapy with peginterferon alpha-2a and ribavirin on the energy intake and body weight of adult hepatitis C patients.

  2008cites this paper
• Interferon-Based Therapy for HCV in People with HCV / HIV Coinfection

  2008cites this paper
• Severe weight loss in HIV / HCV‐coinfected patients treated with interferon plus ribavirin: incidence and risk factors

  2008cites this paper
• Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.

  2008cites this paper
• Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir

  2008cites this paper
• Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders

  2008cites this paper
• Incidence and Risk Factors for Weight Loss During Dual HIV/Hepatitis C Virus Therapy

  2007cites this paper
• Management and therapy of chronic hepatitis C in HIV

  2007cites this paper
• Update on the treatment of chronic hepatitis C in HIV-infected patients.

  2007cites this paper
• Treating hepatitis C virus in HIV patients: are side effects a real obstacle?

  2007cites this paper
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

  2007cites this paper
• COMPORTAMIENTO DEL METABOLISMO LIP˝DICO EN PACIENTES CON VIH/SIDA DE BOGOT` LIPID METABOLISM IN VIH/AIDS PATIENTS IN BOGOT`

  2007cites this paper
• Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

  2007cites this paper
• Antiviral hepatitis and antiretroviral drug interactions.

  2006cites this paper
• Antiretroviral Medication Considerations for Individuals Coinfected with HIV and Hepatitis C Virus

  2006cites this paper
• Chapter 140 – Cryptosporidium parvum Attack (Cryptosporidiosis)

  2006cites this paper
• Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates.

  2006cites this paper
• The Role of Hepatitis C Virus (HCV) in Mitochondrial Dna Damage in HIV/HCV-Coinfected Individuals

  2005cites this paper
• [GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)].

  2005cites this paper
• Response to Interferon-Based Therapies in HIV-Infected Patients with Chronic Hepatitis C Due to Genotype 4

  2005cites this paper
• Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center

  2005cites this paper
• Mitochondrial Dna Depletion in HIV-Infected Patients is More Pronounced with Chronic Hepatitis C and Enhanced following Treatment with Pegylated Interferon plus Ribavirin

  2005cites this paper
• [Hepatitis C and HIV in Spanish prisons].

  2005cites this paper
• Hepatitis C y VIH en prisiones españolas

  2005cites this paper
• Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005)

  2005cites this paper
• Trasplante hepático en pacientes con infección por el VIH: una realidad en el año 2004

  2004cites this paper
• Care of patients with hepatitis C and HIV co-infection.

  2004cites this paper
• Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

  2004cites this paper
• Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

  2004cites this paper
• Long-Term Follow-Up of HIV-Infected Patients with Chronic Hepatitis C Virus Infection Treated with Interferon-Based Therapies

  2004cites this paper
• Hepatitis C: How should we manage the patient?

  2004cites this paper
• Nucleoside analogues and mitochondrial toxicity.

  2004cites this paper
• [Liver transplantation in patients with HIV infection: a reality in 2004].

  2004cites this paper
• HIV and HCV coinfection in haemophilia

  2004cites this paper
• New Hopes for HIV and HCV Coinfection in 2004

  2004cites this paper
• Bilateral enophthalmos as a manifestation of HIV infection‐related lipoatrophy

  2004cites this paper
• Management of Patients with HCV/HIV Co-infection

  2004cites this paper
• How should we manage the patient?

  2004cites this paper
• Hepatitis C Virus-Rna Clearance in HIV-Coinfected Patients with Chronic Hepatitis C Treated with Pegylated Interferon plus Ribavirin

  2003cites this paper
• Toxicity of antiretroviral therapy and implications for drug development

  2003cites this paper
• Coinfection by HIV and hepatitis A , B and C virus in adult patients . Review and GESIDA / PNS recommendations Working group for the elaboration of recommendations on viral hepatitis in HIV-infected patients

  2003cites this paper